• Je něco špatně v tomto záznamu ?

Use of psychedelics in the Czech Republic: results of recent population surveys

P. Chomynová, R. Kočárová, F. Kňažek, M. Plevková, B. Bláhová, K. Valeš, V. Mravčík

. 2022 ; 30 (3) : 144-153. [pub] 20220930

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22026969

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

Odkazy

PubMed 36239361
DOI 10.21101/cejph.a7079
Knihovny.cz E-zdroje

OBJECTIVES: Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general population. The main aim of this study is to estimate the numbers of users of substances with psychedelic properties (classical psychedelics, cannabis, ecstasy, and ketamine) in the Czech Republic. METHODS: Data from two samples enrolled in representative cross-sectional questionnaire surveys in the Czech adult population in 2016 (n = 2,785) and 2018 (n = 1,665) were analysed. Prevalence rates were extrapolated to estimate numbers of current, i.e., last-year, users of psychedelics, and their socio-demographic profiles were compared with non-users and users of cannabis. RESULTS: An estimated 5-6% of the Czech adult population (350-430 thousand people) used classical psychedelics (LSD, psilocybin mushrooms, ayahuasca) in their lifetime, increasing up to 28-30% when cannabis is included (1.9-2.1 million users). Current use of classical psychedelics reached 0.7-1.9% (50-130 thousand people), and 9-11% (590-750 thousand users) when cannabis was included. Users of psychedelics were more often males, of younger age and single. CONCLUSIONS: No significant socio-demographic differences were found between users of classical psychedelics and recreational cannabis users, however, differences were significant when compared to non-users and users of other illicit drugs. Findings should further serve to inform drug policy and social and healthcare systems in respect to the use of psychedelics.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22026969
003      
CZ-PrNML
005      
20230314101943.0
007      
ta
008      
221108s2022 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a7079 $2 doi
035    __
$a (PubMed)36239361
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Chomynová, Pavla $u National Institute of Mental Health, Klecany, Czech Republic $u Czech National Monitoring Centre for Drugs and Addiction, Office of the Government of the Czech Republic, Prague, Czech Republic $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $7 xx0118119
245    10
$a Use of psychedelics in the Czech Republic: results of recent population surveys / $c P. Chomynová, R. Kočárová, F. Kňažek, M. Plevková, B. Bláhová, K. Valeš, V. Mravčík
520    9_
$a OBJECTIVES: Different psychoactive substances are widely used in today's society. So far limited data are available on the use of psychedelics in the general population. The main aim of this study is to estimate the numbers of users of substances with psychedelic properties (classical psychedelics, cannabis, ecstasy, and ketamine) in the Czech Republic. METHODS: Data from two samples enrolled in representative cross-sectional questionnaire surveys in the Czech adult population in 2016 (n = 2,785) and 2018 (n = 1,665) were analysed. Prevalence rates were extrapolated to estimate numbers of current, i.e., last-year, users of psychedelics, and their socio-demographic profiles were compared with non-users and users of cannabis. RESULTS: An estimated 5-6% of the Czech adult population (350-430 thousand people) used classical psychedelics (LSD, psilocybin mushrooms, ayahuasca) in their lifetime, increasing up to 28-30% when cannabis is included (1.9-2.1 million users). Current use of classical psychedelics reached 0.7-1.9% (50-130 thousand people), and 9-11% (590-750 thousand users) when cannabis was included. Users of psychedelics were more often males, of younger age and single. CONCLUSIONS: No significant socio-demographic differences were found between users of classical psychedelics and recreational cannabis users, however, differences were significant when compared to non-users and users of other illicit drugs. Findings should further serve to inform drug policy and social and healthcare systems in respect to the use of psychedelics.
650    _2
$a dospělí $7 D000328
650    12
$a Cannabis $7 D002188
650    _2
$a průřezové studie $7 D003430
650    12
$a halucinogeny $x terapeutické užití $7 D006213
650    _2
$a lidé $7 D006801
650    12
$a zakázané drogy $7 D013287
650    12
$a ketamin $7 D007649
650    _2
$a LSD $7 D008238
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a psilocybin $7 D011562
650    12
$a poruchy spojené s užíváním psychoaktivních látek $x epidemiologie $7 D019966
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kočárová, Rita $u National Institute of Mental Health, Klecany, Czech Republic $u Faculty of Arts, Charles University, Prague, Czech Republic $u Beyond Psychedelics, Prague, Czech Republic $7 xx0256551
700    1_
$a Kňažek, Filip $u National Institute of Mental Health, Klecany, Czech Republic $u Faculty of Pharmacy, Masaryk University, Brno, Czech Republic $7 _AN088117
700    1_
$a Plevková, Michaela $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0283381
700    1_
$a Bláhová, Barbora $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0321393
700    1_
$a Valeš, Karel $u National Institute of Mental Health, Klecany, Czech Republic $7 xx0070865
700    1_
$a Mravčík, Viktor $u National Institute of Mental Health, Klecany, Czech Republic $u Department of Addictology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Spolecnost Podane ruce, Brno, Czech Republic $7 xx0018423
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 30, č. 3 (2022), s. 144-153
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36239361 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20221108 $b ABA008
991    __
$a 20230314101940 $b ABA008
999    __
$a ok $b bmc $g 1896146 $s 1178276
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 30 $c 3 $d 144-153 $e 20220930 $i 1210-7778 $m Central European Journal of Public Health $n Cent. Eur. J. Public Health $x MED00001083
LZP    __
$b NLK198 $a Pubmed-20221108
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace